Atlas Trials

Shambavi Richard

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shambavi Richard

RecordFirmDate
Iberdomide (CC-220) Priming to Improve T Cell Fitness Prior to Leukapheresis for Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Relapsed/Refractory Multiple Myeloma (RRMM) (NCT07727668)Shambavi Richard2026-07-01

Track Shambavi Richard automatically

Every clearance here is in the API, with alerts when new ones post.